Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Familial Amyloid Polyneuropathy Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 FAP-I
1.2.3 FAP-II
1.2.4 FAP-III
1.2.5 FAP-IV
1.3 Market by Application
1.3.1 Global Familial Amyloid Polyneuropathy Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospitals and Clinics
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Familial Amyloid Polyneuropathy Market Perspective (2018-2033)
2.2 Familial Amyloid Polyneuropathy Growth Trends by Region
2.2.1 Global Familial Amyloid Polyneuropathy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Familial Amyloid Polyneuropathy Historic Market Size by Region (2018-2023)
2.2.3 Familial Amyloid Polyneuropathy Forecasted Market Size by Region (2024-2033)
2.3 Familial Amyloid Polyneuropathy Market Dynamics
2.3.1 Familial Amyloid Polyneuropathy Industry Trends
2.3.2 Familial Amyloid Polyneuropathy Market Drivers
2.3.3 Familial Amyloid Polyneuropathy Market Challenges
2.3.4 Familial Amyloid Polyneuropathy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Familial Amyloid Polyneuropathy Players by Revenue
3.1.1 Global Top Familial Amyloid Polyneuropathy Players by Revenue (2018-2023)
3.1.2 Global Familial Amyloid Polyneuropathy Revenue Market Share by Players (2018-2023)
3.2 Global Familial Amyloid Polyneuropathy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Familial Amyloid Polyneuropathy Revenue
3.4 Global Familial Amyloid Polyneuropathy Market Concentration Ratio
3.4.1 Global Familial Amyloid Polyneuropathy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Familial Amyloid Polyneuropathy Revenue in 2022
3.5 Familial Amyloid Polyneuropathy Key Players Head office and Area Served
3.6 Key Players Familial Amyloid Polyneuropathy Product Solution and Service
3.7 Date of Enter into Familial Amyloid Polyneuropathy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Familial Amyloid Polyneuropathy Breakdown Data by Type
4.1 Global Familial Amyloid Polyneuropathy Historic Market Size by Type (2018-2023)
4.2 Global Familial Amyloid Polyneuropathy Forecasted Market Size by Type (2024-2033)
5 Familial Amyloid Polyneuropathy Breakdown Data by Application
5.1 Global Familial Amyloid Polyneuropathy Historic Market Size by Application (2018-2023)
5.2 Global Familial Amyloid Polyneuropathy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Familial Amyloid Polyneuropathy Market Size (2018-2033)
6.2 North America Familial Amyloid Polyneuropathy Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Familial Amyloid Polyneuropathy Market Size by Country (2018-2023)
6.4 North America Familial Amyloid Polyneuropathy Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Familial Amyloid Polyneuropathy Market Size (2018-2033)
7.2 Europe Familial Amyloid Polyneuropathy Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Familial Amyloid Polyneuropathy Market Size by Country (2018-2023)
7.4 Europe Familial Amyloid Polyneuropathy Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Familial Amyloid Polyneuropathy Market Size (2018-2033)
8.2 Asia-Pacific Familial Amyloid Polyneuropathy Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Familial Amyloid Polyneuropathy Market Size by Region (2018-2023)
8.4 Asia-Pacific Familial Amyloid Polyneuropathy Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Familial Amyloid Polyneuropathy Market Size (2018-2033)
9.2 Latin America Familial Amyloid Polyneuropathy Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Familial Amyloid Polyneuropathy Market Size by Country (2018-2023)
9.4 Latin America Familial Amyloid Polyneuropathy Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Familial Amyloid Polyneuropathy Market Size (2018-2033)
10.2 Middle East & Africa Familial Amyloid Polyneuropathy Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Familial Amyloid Polyneuropathy Market Size by Country (2018-2023)
10.4 Middle East & Africa Familial Amyloid Polyneuropathy Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Detail
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Familial Amyloid Polyneuropathy Introduction
11.1.4 Pfizer Revenue in Familial Amyloid Polyneuropathy Business (2018-2023)
11.1.5 Pfizer Recent Development
11.2 GSK
11.2.1 GSK Company Detail
11.2.2 GSK Business Overview
11.2.3 GSK Familial Amyloid Polyneuropathy Introduction
11.2.4 GSK Revenue in Familial Amyloid Polyneuropathy Business (2018-2023)
11.2.5 GSK Recent Development
11.3 Ionis
11.3.1 Ionis Company Detail
11.3.2 Ionis Business Overview
11.3.3 Ionis Familial Amyloid Polyneuropathy Introduction
11.3.4 Ionis Revenue in Familial Amyloid Polyneuropathy Business (2018-2023)
11.3.5 Ionis Recent Development
11.4 Alnylam
11.4.1 Alnylam Company Detail
11.4.2 Alnylam Business Overview
11.4.3 Alnylam Familial Amyloid Polyneuropathy Introduction
11.4.4 Alnylam Revenue in Familial Amyloid Polyneuropathy Business (2018-2023)
11.4.5 Alnylam Recent Development
11.5 Corino Therapeutics
11.5.1 Corino Therapeutics Company Detail
11.5.2 Corino Therapeutics Business Overview
11.5.3 Corino Therapeutics Familial Amyloid Polyneuropathy Introduction
11.5.4 Corino Therapeutics Revenue in Familial Amyloid Polyneuropathy Business (2018-2023)
11.5.5 Corino Therapeutics Recent Development
11.6 Proclara Bioscience
11.6.1 Proclara Bioscience Company Detail
11.6.2 Proclara Bioscience Business Overview
11.6.3 Proclara Bioscience Familial Amyloid Polyneuropathy Introduction
11.6.4 Proclara Bioscience Revenue in Familial Amyloid Polyneuropathy Business (2018-2023)
11.6.5 Proclara Bioscience Recent Development
11.7 Arcturus Therapeutics
11.7.1 Arcturus Therapeutics Company Detail
11.7.2 Arcturus Therapeutics Business Overview
11.7.3 Arcturus Therapeutics Familial Amyloid Polyneuropathy Introduction
11.7.4 Arcturus Therapeutics Revenue in Familial Amyloid Polyneuropathy Business (2018-2023)
11.7.5 Arcturus Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Familial Amyloid Polyneuropathy Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of FAP-I
Table 3. Key Players of FAP-II
Table 4. Key Players of FAP-III
Table 5. Key Players of FAP-IV
Table 6. Global Familial Amyloid Polyneuropathy Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Familial Amyloid Polyneuropathy Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Familial Amyloid Polyneuropathy Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Familial Amyloid Polyneuropathy Market Share by Region (2018-2023)
Table 10. Global Familial Amyloid Polyneuropathy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Familial Amyloid Polyneuropathy Market Share by Region (2024-2033)
Table 12. Familial Amyloid Polyneuropathy Market Trends
Table 13. Familial Amyloid Polyneuropathy Market Drivers
Table 14. Familial Amyloid Polyneuropathy Market Challenges
Table 15. Familial Amyloid Polyneuropathy Market Restraints
Table 16. Global Familial Amyloid Polyneuropathy Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Familial Amyloid Polyneuropathy Market Share by Players (2018-2023)
Table 18. Global Top Familial Amyloid Polyneuropathy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Familial Amyloid Polyneuropathy as of 2022)
Table 19. Ranking of Global Top Familial Amyloid Polyneuropathy Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Familial Amyloid Polyneuropathy Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Familial Amyloid Polyneuropathy Product Solution and Service
Table 23. Date of Enter into Familial Amyloid Polyneuropathy Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Familial Amyloid Polyneuropathy Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Familial Amyloid Polyneuropathy Revenue Market Share by Type (2018-2023)
Table 27. Global Familial Amyloid Polyneuropathy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Familial Amyloid Polyneuropathy Revenue Market Share by Type (2024-2033)
Table 29. Global Familial Amyloid Polyneuropathy Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Familial Amyloid Polyneuropathy Revenue Market Share by Application (2018-2023)
Table 31. Global Familial Amyloid Polyneuropathy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Familial Amyloid Polyneuropathy Revenue Market Share by Application (2024-2033)
Table 33. North America Familial Amyloid Polyneuropathy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Familial Amyloid Polyneuropathy Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Familial Amyloid Polyneuropathy Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Familial Amyloid Polyneuropathy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Familial Amyloid Polyneuropathy Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Familial Amyloid Polyneuropathy Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Familial Amyloid Polyneuropathy Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Familial Amyloid Polyneuropathy Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Familial Amyloid Polyneuropathy Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Familial Amyloid Polyneuropathy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Familial Amyloid Polyneuropathy Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Familial Amyloid Polyneuropathy Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Familial Amyloid Polyneuropathy Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Familial Amyloid Polyneuropathy Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Familial Amyloid Polyneuropathy Market Size by Country (2024-2033) & (US$ Million)
Table 48. Pfizer Company Detail
Table 49. Pfizer Business Overview
Table 50. Pfizer Familial Amyloid Polyneuropathy Product
Table 51. Pfizer Revenue in Familial Amyloid Polyneuropathy Business (2018-2023) & (US$ Million)
Table 52. Pfizer Recent Development
Table 53. GSK Company Detail
Table 54. GSK Business Overview
Table 55. GSK Familial Amyloid Polyneuropathy Product
Table 56. GSK Revenue in Familial Amyloid Polyneuropathy Business (2018-2023) & (US$ Million)
Table 57. GSK Recent Development
Table 58. Ionis Company Detail
Table 59. Ionis Business Overview
Table 60. Ionis Familial Amyloid Polyneuropathy Product
Table 61. Ionis Revenue in Familial Amyloid Polyneuropathy Business (2018-2023) & (US$ Million)
Table 62. Ionis Recent Development
Table 63. Alnylam Company Detail
Table 64. Alnylam Business Overview
Table 65. Alnylam Familial Amyloid Polyneuropathy Product
Table 66. Alnylam Revenue in Familial Amyloid Polyneuropathy Business (2018-2023) & (US$ Million)
Table 67. Alnylam Recent Development
Table 68. Corino Therapeutics Company Detail
Table 69. Corino Therapeutics Business Overview
Table 70. Corino Therapeutics Familial Amyloid Polyneuropathy Product
Table 71. Corino Therapeutics Revenue in Familial Amyloid Polyneuropathy Business (2018-2023) & (US$ Million)
Table 72. Corino Therapeutics Recent Development
Table 73. Proclara Bioscience Company Detail
Table 74. Proclara Bioscience Business Overview
Table 75. Proclara Bioscience Familial Amyloid Polyneuropathy Product
Table 76. Proclara Bioscience Revenue in Familial Amyloid Polyneuropathy Business (2018-2023) & (US$ Million)
Table 77. Proclara Bioscience Recent Development
Table 78. Arcturus Therapeutics Company Detail
Table 79. Arcturus Therapeutics Business Overview
Table 80. Arcturus Therapeutics Familial Amyloid Polyneuropathy Product
Table 81. Arcturus Therapeutics Revenue in Familial Amyloid Polyneuropathy Business (2018-2023) & (US$ Million)
Table 82. Arcturus Therapeutics Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Familial Amyloid Polyneuropathy Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Familial Amyloid Polyneuropathy Market Share by Type: 2022 VS 2033
Figure 3. FAP-I Features
Figure 4. FAP-II Features
Figure 5. FAP-III Features
Figure 6. FAP-IV Features
Figure 7. Global Familial Amyloid Polyneuropathy Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Familial Amyloid Polyneuropathy Market Share by Application: 2022 VS 2033
Figure 9. Hospitals and Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Familial Amyloid Polyneuropathy Report Years Considered
Figure 12. Global Familial Amyloid Polyneuropathy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Familial Amyloid Polyneuropathy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Familial Amyloid Polyneuropathy Market Share by Region: 2022 VS 2033
Figure 15. Global Familial Amyloid Polyneuropathy Market Share by Players in 2022
Figure 16. Global Top Familial Amyloid Polyneuropathy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Familial Amyloid Polyneuropathy as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Familial Amyloid Polyneuropathy Revenue in 2022
Figure 18. North America Familial Amyloid Polyneuropathy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Familial Amyloid Polyneuropathy Market Share by Country (2018-2033)
Figure 20. United States Familial Amyloid Polyneuropathy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Canada Familial Amyloid Polyneuropathy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Europe Familial Amyloid Polyneuropathy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Familial Amyloid Polyneuropathy Market Share by Country (2018-2033)
Figure 24. Germany Familial Amyloid Polyneuropathy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. France Familial Amyloid Polyneuropathy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. U.K. Familial Amyloid Polyneuropathy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Italy Familial Amyloid Polyneuropathy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Russia Familial Amyloid Polyneuropathy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Nordic Countries Familial Amyloid Polyneuropathy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Asia-Pacific Familial Amyloid Polyneuropathy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Familial Amyloid Polyneuropathy Market Share by Region (2018-2033)
Figure 32. China Familial Amyloid Polyneuropathy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Japan Familial Amyloid Polyneuropathy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. South Korea Familial Amyloid Polyneuropathy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Southeast Asia Familial Amyloid Polyneuropathy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. India Familial Amyloid Polyneuropathy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Australia Familial Amyloid Polyneuropathy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Latin America Familial Amyloid Polyneuropathy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Familial Amyloid Polyneuropathy Market Share by Country (2018-2033)
Figure 40. Mexico Familial Amyloid Polyneuropathy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Brazil Familial Amyloid Polyneuropathy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Middle East & Africa Familial Amyloid Polyneuropathy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Familial Amyloid Polyneuropathy Market Share by Country (2018-2033)
Figure 44. Turkey Familial Amyloid Polyneuropathy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Saudi Arabia Familial Amyloid Polyneuropathy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Pfizer Revenue Growth Rate in Familial Amyloid Polyneuropathy Business (2018-2023)
Figure 47. GSK Revenue Growth Rate in Familial Amyloid Polyneuropathy Business (2018-2023)
Figure 48. Ionis Revenue Growth Rate in Familial Amyloid Polyneuropathy Business (2018-2023)
Figure 49. Alnylam Revenue Growth Rate in Familial Amyloid Polyneuropathy Business (2018-2023)
Figure 50. Corino Therapeutics Revenue Growth Rate in Familial Amyloid Polyneuropathy Business (2018-2023)
Figure 51. Proclara Bioscience Revenue Growth Rate in Familial Amyloid Polyneuropathy Business (2018-2023)
Figure 52. Arcturus Therapeutics Revenue Growth Rate in Familial Amyloid Polyneuropathy Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed